Logo image of OBLG

OBLONG INC (OBLG) Stock Fundamental Analysis

NASDAQ:OBLG - Nasdaq - US6744343038 - Common Stock - Currency: USD

3.94  +0.35 (+9.75%)

After market: 3.92 -0.02 (-0.51%)

Fundamental Rating

2

Taking everything into account, OBLG scores 2 out of 10 in our fundamental rating. OBLG was compared to 284 industry peers in the Software industry. No worries on liquidiy or solvency for OBLG as it has an excellent financial health rating, but there are worries on the profitability. OBLG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

OBLG had negative earnings in the past year.
OBLG had a negative operating cash flow in the past year.
OBLG had negative earnings in each of the past 5 years.
OBLG had a negative operating cash flow in each of the past 5 years.
OBLG Yearly Net Income VS EBIT VS OCF VS FCFOBLG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

OBLG has a worse Return On Assets (-248.45%) than 95.07% of its industry peers.
With a Return On Equity value of -327.40%, OBLG is not doing good in the industry: 81.34% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -248.45%
ROE -327.4%
ROIC N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
OBLG Yearly ROA, ROE, ROICOBLG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

With a Gross Margin value of 13.92%, OBLG is not doing good in the industry: 84.86% of the companies in the same industry are doing better.
OBLG's Gross Margin has declined in the last couple of years.
OBLG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
OBLG Yearly Profit, Operating, Gross MarginsOBLG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

7

2. Health

2.1 Basic Checks

OBLG does not have a ROIC to compare to the WACC, probably because it is not profitable.
OBLG has less shares outstanding than it did 1 year ago.
The number of shares outstanding for OBLG has been increased compared to 5 years ago.
OBLG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OBLG Yearly Shares OutstandingOBLG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
OBLG Yearly Total Debt VS Total AssetsOBLG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

OBLG has an Altman-Z score of -60.97. This is a bad value and indicates that OBLG is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -60.97, OBLG is doing worse than 96.13% of the companies in the same industry.
OBLG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -60.97
ROIC/WACCN/A
WACC10.9%
OBLG Yearly LT Debt VS Equity VS FCFOBLG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

OBLG has a Current Ratio of 4.14. This indicates that OBLG is financially healthy and has no problem in meeting its short term obligations.
OBLG has a better Current ratio (4.14) than 80.63% of its industry peers.
A Quick Ratio of 4.14 indicates that OBLG has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.14, OBLG belongs to the top of the industry, outperforming 80.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 4.14
OBLG Yearly Current Assets VS Current LiabilitesOBLG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. Growth

3.1 Past

OBLG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -683.88%.
OBLG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.65%.
Measured over the past years, OBLG shows a very negative growth in Revenue. The Revenue has been decreasing by -28.62% on average per year.
EPS 1Y (TTM)-683.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-788.8%
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-40.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OBLG Yearly Revenue VS EstimatesOBLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
OBLG Yearly EPS VS EstimatesOBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 -200 -400 -600 -800 -1K

0

4. Valuation

4.1 Price/Earnings Ratio

OBLG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OBLG Price Earnings VS Forward Price EarningsOBLG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OBLG Per share dataOBLG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

OBLG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OBLONG INC

NASDAQ:OBLG (5/16/2025, 6:48:52 PM)

After market: 3.92 -0.02 (-0.51%)

3.94

+0.35 (+9.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-06 2025-05-06
Earnings (Next)08-05 2025-08-05
Inst Owners1.2%
Inst Owner Change0.02%
Ins Owners0.17%
Ins Owner Change0%
Market Cap4.53M
Analysts82.86
Price TargetN/A
Short Float %8.45%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.91
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)-13.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.96
FCFYN/A
OCF(TTM)-2.96
OCFYN/A
SpS2.07
BVpS3.48
TBVpS3.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -248.45%
ROE -327.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.92%
FCFM N/A
ROA(3y)-237.61%
ROA(5y)-155.05%
ROE(3y)-345.63%
ROE(5y)-222.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.56%
GM growth 5Y-19.85%
F-Score2
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 4.14
Altman-Z -60.97
F-Score2
WACC10.9%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-683.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-788.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.65%
Revenue growth 3Y-32.52%
Revenue growth 5Y-28.62%
Sales Q2Q%-40.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.8%
OCF growth 3YN/A
OCF growth 5YN/A